[1]迟皓南,孙小慧,杨毅.基于网络药理学的二仙汤“异病同治”乳腺增生和围绝经期综合征的作用机制[J].西部中医药,2024,37(01):80-87.[doi:10.12174/j.issn.2096-9600.2024.01.17]
　CHI Haonan,SUN Xiaohui,YANG Yi.Network Pharmacology-based Research into the Mechanism of the Treatment of Mammary Hyperplasia and Perimenopausal Syndrome by Erxian Tang Based on "the Same Therapy for Different Diseases"[J].Western Journal of Traditional Chinese Medicine,2024,37(01):80-87.[doi:10.12174/j.issn.2096-9600.2024.01.17]
点击复制

基于网络药理学的二仙汤“异病同治”乳腺增生和围绝经期综合征的作用机制
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
37
期数:
2024年01期
页码:
80-87
栏目:
二次研究
出版日期:
2024-01-15

文章信息/Info

Title:
Network Pharmacology-based Research into the Mechanism of the Treatment of Mammary Hyperplasia and Perimenopausal Syndrome by Erxian Tang Based on "the Same Therapy for Different Diseases"
作者:
迟皓南1, 孙小慧2, 杨毅2
1.山东中医药大学中医学院，山东 济南 250014
2.山东中医药大学附属医院乳腺甲状腺外科，山东 济南 250011
Author(s):
CHI Haonan1, SUN Xiaohui2, YANG Yi2
1.Traditional Chinese Medicine School, Shandong University of Traditional Chinese Medicine, Jinan 250014, China
2.Breast and Thyroid Surgery, Affiliated Hospital to Shandong University of Traditional Chinese Medicine, Jinan 250011, China
关键词:
乳腺增生; 围绝经期综合征; 异病同治; 网络药理学; 二仙汤
Keywords:
mammary hyperplasia; perimenopausal syndrome; the same therapy for different diseases; network pharmacology
分类号:
R271.9
DOI:
10.12174/j.issn.2096-9600.2024.01.17
文献标志码:
A
摘要:
目的基于网络药理学探讨二仙汤“异病同治”乳腺增生和围绝经期综合征的作用机制。 方法通过中药系统药理学数据库与分析平台（traditional Chinese medicine systems pharmacology database and analysis platform，TCMSP）筛选二仙汤中6味中药的活性成分并预测其潜在靶点；通过人类基因数据库（the human gene database，GeneCards）及在线人类孟德尔遗传数据库（online mendelian inheritance in man，OMIM）平台检索乳腺增生和围绝经期综合征的疾病靶点，借助Venn在线工具构建药物与两种疾病的交集靶点。运用Cytoscape 3.7.2软件构建“药物-成分-靶点-疾病”网络；利用STRING数据库构建PPI网络，按Dgree值大于等于平均值进一步筛选核心靶点；采用DAVID数据库进行基因本体论（gene ontology，GO）富集分析，同时实现京都基因与基因组百科全书（kyoto encyclopedia of genes and genomes，KEGG）通路富集分析。 结果根据口服生物利用度（oral bioavailability，OB）≥30%和药物类药性（drug-likeness，DL）≥0.18筛选得到二仙汤有效活性成分104个，预测潜在作用靶点147个；通过筛选得到乳腺增生靶点4153个，围绝经期综合征靶点155个，药物与疾病的交集靶点29个，其中IL-6、VEGFA、TNF、TP53、ESR1、CAT、IL-1β等可能是二仙汤治疗乳腺增生和围绝经期综合征的关键靶点。活性成分及靶点主要参与DNA模板转录正调控、基因表达的正调控、胞外间隙、胞外区、类固醇结合、酶结合等；靶基因主要富集在TNF、NOD样体、HIF-1、癌症、PI3K-Akt等信号通路。 结论二仙汤可能通过调控PI3K-Akt、HIF-1等信号通路达到防治乳腺增生和围绝经期综合征的目的。
Abstract:
ObjectiveTo explore the mechanism of the treatment of mammary hyperplasia and perimenopausal syndrome by Erxian Tang based on "the same therapy for different diseases" using network pharmacology. MethodsTo survey the mechanism of treating mammary hyperplasia and perimenopausal syndrome (PMS) by Erxian Tang based on network pharmacology and "the same therapy for different diseases". MethodsThe effective active ingredients of six drugs in Erxian Tang were searched and screened via TCMSP, and its potential targets were predicted; disease targets of mammary hyperplasia and PMS were searched via GeneCards and OMIM, the intersection targets between drugs and two kinds of diseases were constructed via Venn online tool. The network of "drug-ingredients-targets-disease" was built using Cytoscape 3.7.2 software; PPI network was established utilizing STRING database, to further screen the core targets in light of degree values≥the average one; GO and KEGG pathway enrichment analysis were performed using DAVID database. ResultsAll 104 effective active ingredients were screened according to OB≥30% and DL≥0.18, and 147 potential targets were predicted; 4153 targets of mammary hyperplasia and 155 targets related to PMS were gained, and 26 intersected targets of disease and drug, among which, IL-6, VEGFA, TNF, TP53, ESR1, CAT and IL-1β might be the key targets of Erxian Tang in the treatment of mammary hyperplasia and PMS. Active ingredients and targets mainly participated in positive regulation of DNA template transcription, positive regulation of gene expression, extracellular gap, extracellular region, steroid binding and enzyme binding; target genes were mainly enriched in TNF signaling pathway, NOD-like receptor signaling pathway, HIF-1 signaling pathway, cancer signaling pathway and PI3K-Akt signaling pathway. ConclusionErxian Tang could prevent and treat mammary hyperplasia and PMS possibly through regulating PI3K-Akt and HIF-1 signal pathways.

相似文献/References:

[1]李小梅,潘耀军,肖家玲,等.吴克明教授运用滋水清肝饮化裁治疗围绝经期综合征的经验[J].西部中医药,2011,24(11):15.
[2]张春霞,李晓琴△,孙亮,等.平衡针刺配合桂枝茯苓丸治疗乳腺囊性增生疗效观察[J].西部中医药,2013,26(08):111.
　ZHANG Chunxia,LI Xiaoqin,SUN Liang,et al.Clinical Observation on Balance Acupuncture and GuiZhi FuLingWan for Cystic Hyperplasia of Mammary Glands[J].Western Journal of Traditional Chinese Medicine,2013,26(01):111.
[3]王玉兰.健康知识教育联合生活习惯护理在体检发现乳腺增生患者护理中的应用价值[J].西部中医药,2014,27(02):122.
　WANG Yulan.Application of Health Education and Living Habits Care to the Patients with Hyperplasia of Mammary Glands Found in Health Examination[J].Western Journal of Traditional Chinese Medicine,2014,27(01):122.
[4]周朝晖,刘鸿雁,安晓芳,等.安乳消痛丸对乳腺增生模型大鼠的影响[J].西部中医药,2016,29(04):26.
　ZHOU Chaohui,LIU Hongyan,AN Xiaofang,et al.Effects of AnRu XiaoTong Pills on the Rat Model with Mammary Gland Hyperplasia[J].Western Journal of Traditional Chinese Medicine,2016,29(01):26.
[5]杨继若,姚贞宇,许会英,等.针灸结合甘麦大枣汤加减治疗围绝经期综合征疗效观察[J].西部中医药,2018,31(05):104.
　YANG Jiruo,YAO Zhenyu,XU Huiying,et al.Observation on Clinical Effects of Needling Combined with Modified GanMai DaZao Decoction in Treating Perimenopausal Syndrome[J].Western Journal of Traditional Chinese Medicine,2018,31(01):104.
[6]陈萍,蒋娟梅,田小刚,等.基于超声监测观察柴玄消癖汤治疗乳腺增生症的疗效[J].西部中医药,2018,31(07):131.
　CHEN Ping,JIANG Juanmei,TIAN Xiaogang,et al.Clinical Observation on ChaiXuan XiaoPi Decoction in Treating Cyclomastopathy Based on Ultrasonic Monitoring[J].Western Journal of Traditional Chinese Medicine,2018,31(01):131.
[7]李随阳.乳癖汤联合乳腺热敷包治疗乳腺增生临床疗效[J].西部中医药,2019,32(01):115.
　LI Suiyang.Clinical Effects of RuPi Decoction Combined with Mammary Gland Package for External Application in the Treatment for Hyperplasia of Mammary Glands[J].Western Journal of Traditional Chinese Medicine,2019,32(01):115.
[8]王洪雪,王杰琼,高杰.围绝经期综合征的中医药研究进展[J].西部中医药,2022,35(07):144.[doi:10.12174/j.issn.2096-9600.2022.07.37]
　WANG Hongxue,WANG Jieqiong,GAO Jie.TCM Research Progress of Peripheral Menopausal Syndrome[J].Western Journal of Traditional Chinese Medicine,2022,35(01):144.[doi:10.12174/j.issn.2096-9600.2022.07.37]
[9]程巍,李长慧,王艳萍.“围绝经期综合征”中医健康状态辨识体系专家共识[J].西部中医药,2021,34(09):89.[doi:10.12174/j.issn.2096-9600.2021.09.24]
　CHENG Wei,LI Changhui,WANG Yanping.Expert Consensus on TCM Health Status Identification System of “Perimenopausal Syndrome”[J].Western Journal of Traditional Chinese Medicine,2021,34(01):89.[doi:10.12174/j.issn.2096-9600.2021.09.24]
[10]郑君,王煜.国医大师王自立教授运用归芍运脾汤治疗脾虚肝郁型乳腺增生经验[J].西部中医药,2022,35(11):82.[doi:10.12174/j.issn.2096-9600.2022.11.15]
　ZHENG Jun,WANG Yu.TCM Master Wang Zili 's Experience in Treating Hyperplasia of Mammary Glands of Spleen-deficiency Liver-depression Pattern by Guishao Yunpi Tang[J].Western Journal of Traditional Chinese Medicine,2022,35(01):82.[doi:10.12174/j.issn.2096-9600.2022.11.15]

备注/Memo

备注/Memo:
迟皓南（1996—），女，在读硕士研究生。研究方向：乳腺、甲状腺疾病的中医及中西医治疗。
更新日期/Last Update: 2024-01-15